Literature DB >> 10480701

Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study.

J Hedman1, J Kaprio, T Poussa, M M Nieminen.   

Abstract

BACKGROUND: Remarkable overlap exists in symptoms between asthma and chronic obstructive pulmonary disease (COPD), and the symptoms of the patients with mild asthma are often falsely thought to be caused by smoking. The objective of the study was to determine the prevalence of doctor-diagnosed asthma, asthmatic symptoms and doctor-diagnosed COPD in an adult population. The prevalence and relation to asthma of aspirin intolerance, nasal polyposis, allergic rhinitis and smoking habits were also examined.
METHODS: Postal questionnaire survey of a population-based random sample (4300) of adult women and men aged 18-65 years served by the Päijät-Häme Central Hospital in southern Finland (a region with 208 000 inhabitants) was performed.
RESULTS: The non-response-adjusted prevalence (Drane's linear method) of doctor-diagnosed asthma was 4.4% (95% CI: 3.3-5.5%) and of COPD 3.7% (95% CI: 2.7-4.8%). The prevalence of allergic rhinitis was 37.3% (95% CI: 33.3-41.2%), and of overall aspirin intolerance 5.7% (95% CI: 4.4-7.1%). The observed prevalence of aspirin intolerance causing shortness of breath or attacks of asthma was 1.2% and it was higher in patients with doctor-diagnosed asthma than without (8.8% versus 0.8%, relative risk [RR] = 11.4, P < 0.0001), and higher in those with allergic-like rhinitis than without (2.6% versus 0.3%, RR = 7.7, P < 0.0001). The prevalence of nasal polyposis was 4.3% (95% CI : 2.8-5.8%).
CONCLUSIONS: The current prevalence of doctor-diagnosed asthma among adults is 4.4%, and allergic rhinitis, nasal polyposis and aspirin intolerance are associated with an increased risk of asthma. There is also association between aspirin-induced asthma and allergic-like rhinitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480701     DOI: 10.1093/ije/28.4.717

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  103 in total

Review 1.  Nasal polyposis, eosinophil dominated inflammation, and allergy.

Authors:  N Mygind; R Dahl; C Bachert
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  KIF3A, a cilia structural gene on chromosome 5q31, and its polymorphisms show an association with aspirin hypersensitivity in asthma.

Authors:  Jeong-Hyun Kim; Ji-Yeon Cha; Hyun Sub Cheong; Jong Sook Park; An Soo Jang; Soo-Taek Uh; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Byung-Lae Park; Joon Seol Bae; Choon-Sik Park; Hyoung Doo Shin
Journal:  J Clin Immunol       Date:  2010-10-05       Impact factor: 8.317

3.  Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis.

Authors:  Benjamin Z Galper; Andrew Moran; Pamela G Coxson; Mark J Pletcher; Paul Heidenreich; Lawrence D Lazar; Nicolas Rodondi; Y Claire Wang; Lee Goldman
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

4.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

Review 5.  Management of chronic rhinosinusitis in asthma patients: is there still a debate?

Authors:  Eduardo Lehrer; Joaquim Mullol; Freddy Agredo; Isam Alobid
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

6.  ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population.

Authors:  Takuro Sakagami; Nobuyoshi Jinnai; Toshiaki Nakajima; Takashi Sekigawa; Takashi Hasegawa; Eiichi Suzuki; Ituro Inoue; Fumitake Gejyo
Journal:  J Hum Genet       Date:  2006-10-24       Impact factor: 3.172

Review 7.  Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).

Authors:  Ronald A Simon; Kristen M Dazy; Jeremy D Waldram
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

8.  Endoscopic sinus surgery in chronic rhinosinusitis and nasal polyposis: a comparative study.

Authors:  Satish Nair; Angshuman Dutta; Ramakrishnan Rajagopalan; Sapna Nambiar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-01-18

Review 9.  The use of analgesics in patients with asthma.

Authors:  S Levy; G Volans
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

10.  Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy.

Authors:  I Gerlinger; A Fittler; F Fónai; A Patzkó; A Mayer; L Botz
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-25       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.